Strides Pharma shares hit 52-week high as company's unit receives USFDA approval for Icosapent Ethyl capsules
Strides Pharma news: Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, received USFDA (United States Food and Drug Administration) approval for Icosapent Ethyl Capsules 0.5 gram and 1 gram.
Strides Pharma share price NSE, Strides Pharma news: Strides Pharma Science shares gained over 4 per cent on the NSE in morning deals on Monday, September 25. Image: Official website